» Articles » PMID: 29716996

Calcium-dependent Phosphorylation of Serine Repeat Antigen 5 Triggers Merozoite Egress

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2018 May 3
PMID 29716996
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The human malaria parasite proliferates in red blood cells following repeated cycles of invasion, multiplication, and egress. serine repeat antigen 5 (PfSERA5), a putative serine protease, plays an important role in merozoite egress. However, regulation of its activity leading to merozoite egress is poorly understood. In this study, we show that PfSERA5 undergoes phosphorylation prior to merozoite egress. Immunoprecipitation of parasite lysates using anti-PfSERA5 serum followed by MS analysis identified calcium-dependent protein kinase 1 (PfCDPK1) as an interacting kinase. Association of PfSERA5 with PfCDPK1 was corroborated by co-sedimentation, co-immunoprecipitation, and co-immunolocalization analyses. Interestingly, PfCDPK1 phosphorylated PfSERA5 in the presence of Ca and enhanced its proteolytic activity. A PfCDPK1 inhibitor, purfalcamine, blocked the phosphorylation and activation of PfSERA5 both as well as in schizonts, which, in turn, blocked merozoite egress. Together, these results suggest that phosphorylation of PfSERA5 by PfCDPK1 following a rise in cytosolic Ca levels activates its proteolytic activity to trigger merozoite egress.

Citing Articles

Predicting kinase inhibitors from antimalarial medicinal herbs using computational modeling approach.

Adelusi T, Ojo T, Bolaji O, Oyewole M, Olaoba O, Oladipo E In Silico Pharmacol. 2023; 12(1):4.

PMID: 38130691 PMC: 10730500. DOI: 10.1007/s40203-023-00175-z.


Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.

Bougouma E, Palacpac N, Tiono A, Nebie I, Ouedraogo A, Houard S Front Immunol. 2022; 13:978591.

PMID: 36119062 PMC: 9471861. DOI: 10.3389/fimmu.2022.978591.


Targeting the proteome and organelles for potential antimalarial drug candidates.

Abugri J, Ayariga J, Sunwiale S, Wezena C, Gyamfi J, Adu-Frimpong M Heliyon. 2022; 8(8):e10390.

PMID: 36033316 PMC: 9398786. DOI: 10.1016/j.heliyon.2022.e10390.


CDPKs: The critical decoders of calcium signal at various stages of malaria parasite development.

Sharma M, Choudhury H, Roy R, Michaels S, Ojo K, Bansal A Comput Struct Biotechnol J. 2021; 19:5092-5107.

PMID: 34589185 PMC: 8453137. DOI: 10.1016/j.csbj.2021.08.054.


Calcium in the Backstage of Malaria Parasite Biology.

Oliveira L, Alborghetti M, Carneiro R, Bastos I, Amino R, Grellier P Front Cell Infect Microbiol. 2021; 11:708834.

PMID: 34395314 PMC: 8355824. DOI: 10.3389/fcimb.2021.708834.


References
1.
Aly A, Matuschewski K . A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J Exp Med. 2005; 202(2):225-30. PMC: 2213010. DOI: 10.1084/jem.20050545. View

2.
Ashley E, Dhorda M, Fairhurst R, Amaratunga C, Lim P, Suon S . Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014; 371(5):411-23. PMC: 4143591. DOI: 10.1056/NEJMoa1314981. View

3.
Lopez-Otin C, Hunter T . The regulatory crosstalk between kinases and proteases in cancer. Nat Rev Cancer. 2010; 10(4):278-92. DOI: 10.1038/nrc2823. View

4.
Hanspal M, Dua M, Takakuwa Y, Chishti A, Mizuno A . Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood. 2002; 100(3):1048-54. DOI: 10.1182/blood-2002-01-0101. View

5.
Kato N, Sakata T, Breton G, Le Roch K, Nagle A, Andersen C . Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility. Nat Chem Biol. 2008; 4(6):347-56. PMC: 11892688. DOI: 10.1038/nchembio.87. View